MedPath
HSA Approval

Difflam™ Anti-inflammatory Lozenge (with antibacterial) (Eucalyptus and Menthol)

SIN13591P

Difflam™ Anti-inflammatory Lozenge (with antibacterial) (Eucalyptus and Menthol)

Difflam™ Anti-inflammatory Lozenge (with antibacterial) (Eucalyptus and Menthol)

January 22, 2009

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantINOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED
Licence HolderINOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

LOZENGE

**HOW TO USE THIS MEDICINE** ![Difflam Lozenge (Eucalyptus And Menthol) Dosage Table 1](https://cdn.medpath.com/drug/dosage/20240520/ca8f95bbe1261b568fd849d560f654c8.png)

ORAL

Medical Information

**USE THIS MEDICINE FOR** Fast relief from the symptoms of: - Sore throat - Pharyngitis - Tonsillitis - Mouth ulcers - Swelling, redness and inflammatory conditions - Pain following mouth or throat surgery - Pain following dental procedures

**DO NOT USE THIS MEDICINE IF** You are allergic to benzydamine or other anti-inflammatory medicines. If an allergic reaction occurs, stop taking and see your doctor immediately.

A01AD02

benzydamine

Manufacturer Information

INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED

Unique Pharmaceuticals Laboratories

Active Ingredients

BENZYDAMINE HYDROCHLORIDE

3.0mg

Benzydamine

CETYLPYRIDINIUM CHLORIDE

1.33mg

Documents

Patient Information Leaflets

Difflam lozenges Eucalyptus Menthol Outer Carton.pdf

Approved: March 12, 2019

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Difflam™ Anti-inflammatory Lozenge (with antibacterial) (Eucalyptus and Menthol) - HSA Approval | MedPath